{"url_path":"/sec/wgrx/8-k/2026-05-19/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-024324-index.html","accession_number":"0001493152-26-024324","cik":"0002030763","ticker":"WGRX","issuer_name":"Wellgistics Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-024324-index.html","primary_entity_key":"0002030763","primary_entity_name":"Wellgistics Health, Inc."},"word_count":147,"has_tables":true,"body_markdown":"**Item\n7.01 Regulation FD Disclosure.**\n\n** **\n\nOn\nMay 15, 2026, Wellgistics Health, Inc. issued a press release announcing that it will report its financial results for the first quarter\nof 2026 on Tuesday, May 19, 2026 after market close. A copy of the press release is furnished as Exhibit 99.1 to this Current Report\non Form 8-K and is incorporated herein by reference.\n\n \n\nThe\ninformation contained in this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed”\nfor purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that section, nor\nshall it be deemed incorporated by reference into any filing of Wellgistics Health, Inc. under the Securities Act of 1933, as amended,\nor the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference in such filing."}